Insider’s View: Deciphering Catheter Precision Inc (VTAK)’s Financial Health Through Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

The price of Catheter Precision Inc (AMEX: VTAK) closed at $0.22 in the last session, down -5.65% from day before closing price of $0.23. In other words, the price has decreased by -$5.65 from its previous closing price. On the day, 1.12 million shares were traded. VTAK stock price reached its highest trading level at $0.23 during the session, while it also had its lowest trading level at $0.2102.

Ratios:

We take a closer look at VTAK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.19 and its Current Ratio is at 0.21. In the meantime, Its Debt-to-Equity ratio is 1.53 whereas as Long-Term Debt/Eq ratio is at 1.31.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Jaffray on August 13, 2019, Downgraded its rating to Neutral and sets its target price to $1.50 from $9 previously.

On November 02, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $23.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 29 ’25 when COLOMBATTO MARTIN J sold 3 shares for $0.40 per share. The transaction valued at 1 led to the insider holds 0 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTAK now has a Market Capitalization of 2756804 and an Enterprise Value of 2149686. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.75 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at 4.469 whereas that against EBITDA is -0.216.

Stock Price History:

The Beta on a monthly basis for VTAK is -0.64, which has changed by -0.87134504 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, VTAK has reached a high of $2.49, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -14.51%, while the 200-Day Moving Average is calculated to be -40.13%.

Shares Statistics:

According to the various share statistics, VTAK traded on average about 14.51M shares per day over the past 3-months and 2859790 shares per day over the past 10 days. A total of 12.59M shares are outstanding, with a floating share count of 11.80M. Insiders hold about 6.33% of the company’s shares, while institutions hold 4.67% stake in the company. Shares short for VTAK as of 1752537600 were 369602 with a Short Ratio of 0.03, compared to 1749772800 on 3259022. Therefore, it implies a Short% of Shares Outstanding of 369602 and a Short% of Float of 2.9899999999999998.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.